-
1.发明申请公开(公告)号：US20110196283A1
公开(公告)日：2011-08-11
申请号：US13024295
申请日：2011-02-09
IPC分类号： A61N1/30
CPC分类号： A61N1/303 , A61N1/044 , A61N1/0448 , A61N1/325
摘要： Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontohoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
摘要翻译： 本发明的实施方案提供了用于优化透皮离子电渗药物递送的功率利用的结构，系统和方法，其将离子电渗驱动电压维持在降低或甚至最小值以支持离子电渗疗法输送电流。 降低的电压降低了药物递送期间透皮离子电泳递送系统的功率需求。 用于实现该方法的体系结构的实施例可以利用将期望电流与实际电流进行比较的控制器，并且调节电压以减少用于离子电渗药物递送的功率量。 控制器可以包括状态机或微处理器。 本发明的实施方案对于延长透皮离子电渗药物递送系统的电池寿命特别有用。
-
2.发明授权Methods and architecture for power optimization of iontophoretic transdermal drug delivery 有权离子电渗透皮药物传递功率优化的方法和架构公开(公告)号：US08986279B2
公开(公告)日：2015-03-24
申请号：US13024295
申请日：2011-02-09
CPC分类号： A61N1/303 , A61N1/044 , A61N1/0448 , A61N1/325
摘要： Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontohoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
摘要翻译： 本发明的实施方案提供了用于优化透皮离子电渗药物递送的功率利用的结构，系统和方法，其将离子电渗驱动电压维持在降低或甚至最小值以支持离子电渗疗法输送电流。 降低的电压降低了药物递送期间透皮离子电泳递送系统的功率需求。 用于实现该方法的体系结构的实施例可以利用将期望电流与实际电流进行比较的控制器，并且调节电压以减少用于离子电渗药物递送的功率量。 控制器可以包括状态机或微处理器。 本发明的实施方案对于延长透皮离子电渗药物递送系统的电池寿命特别有用。
-
3.发明授权Establishing secure communication between an implantable medical device and an external device 有权建立可植入医疗设备和外部设备之间的安全通信公开(公告)号：US08707040B2
公开(公告)日：2014-04-22
申请号：US13286065
申请日：2011-10-31
申请人： Dean P. Andersen
发明人： Dean P. Andersen
IPC分类号： H04L29/06
CPC分类号： H04L9/0869 , A61B5/0006 , A61B5/0031 , A61B5/04001 , A61B5/0476 , A61B5/076 , A61B5/6868 , A61N1/36064 , G06F7/588 , G06F19/00 , G06F21/606 , G16H40/63 , H04L9/0816 , H04L63/0442 , H04L63/0823 , H04L63/0861 , H04L67/12 , H04L2209/24 , H04W12/04 , H04W12/06
摘要： Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
摘要翻译： 建立可植入医疗装置与外部装置之间的安全通信包括：在可植入医疗装置处访问生物数据; 在可植入医疗装置处利用生物数据产生公共密码密钥; 以及在可植入医疗装置处利用公共密码密钥产生专用密码密钥。
-
4.发明申请公开(公告)号：US20130108046A1
公开(公告)日：2013-05-02
申请号：US13286065
申请日：2011-10-31
申请人： Dean P. ANDERSEN
发明人： Dean P. ANDERSEN
CPC分类号： H04L9/0869 , A61B5/0006 , A61B5/0031 , A61B5/04001 , A61B5/0476 , A61B5/076 , A61B5/6868 , A61N1/36064 , G06F7/588 , G06F19/00 , G06F21/606 , G16H40/63 , H04L9/0816 , H04L63/0442 , H04L63/0823 , H04L63/0861 , H04L67/12 , H04L2209/24 , H04W12/04 , H04W12/06
摘要： Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
-
-
-
搜索结果
4 条记录 (耗时 0.012 秒)
